Orientações sobre procedimentos de análise de produtos biológicos
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4231658
Webinário discute convergência regulatória
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4231481
Jamaica: Ministry of Health Warns Against the use of Unregistered Cannabis Products for Medical and Therapeutic Purposes
The Ministry of Health is advising the public against the use of unregistered Cannabis Products for medical and therapeutic purposes.
The Ministry of Health recommends that Medical Cannabis products have a maximum Tetrahydrocannabinol (THC) content of 5% and is concerned about the potential negative public health effects that may arise from the use of unregistered cannabis products of which the (THC) content is unknown. Tetrahydrocannabinol (THC) is the main mind-altering ingredient found in the Cannabis plant.
According to the Food and Drugs Act, any substance manufactured, sold or represented for use in the diagnosis, treatment, prevention of a disease, disorder or symptoms is classified as a drug and must be registered, and the requisite permits obtained from the Ministry of Health.
Additionally, the Dangerous Drugs (Amendment) Act, 2015 which has decriminalized ganja for specific purposes, cannabis remains classified as a controlled drug under the Food and Drugs Act (1975). Also, in accordance with the provisions of the Pharmacy Act, the compounding, dispensing, storing for sale or retailing of drugs must be done at a registered pharmacy and by a registered pharmacist. Therefore, any company that is currently selling cannabis products for medical and therapeutic purposes is in breach of The Food and Drugs Act (1975) and The Pharmacy Act.
Companies are being advised to consult with the Ministry of Health’s Standards and Regulations Department, Pharmacy Council of Jamaica and the Cannabis Licensing Authority if they wish to manufacture or distribute cannabis products, to ensure that proper standards and procedures are followed and that their operations are in keeping with the relevant laws of Jamaica.
There is a process in place for registration of Medical and Therapeutic Cannabis Product that starts with the application for registration by the Ministry of Health.
The Ministry of Health wishes to reiterate that it does not support, for medicinal and therapeutic purposes, the smoking of cannabis and the use of edibles containing cannabis.
Anvisa realiza reunião pública para debater agrotóxicos
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4230375
Comissão analisará solicitação da situação documental
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4230159
Como fazer: Regularização de Débitos não Tributários
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4226488
Scholarships available for the one-week course on clinical research in Boston
Use of Big Health Care Data for Clinical Research
Each session’s topic seeks to promote an exchange of knowledge and experiences amongst participants, and to inspire new lines of research across borders.
The speakers are prestigious professors who have extensive teaching and research experience and whose work has been widely published in their respective fields. Sessions are structured around the presentation of articles, case studies, and work of the speakers themselves, presenting reviews of their work and the current state of issues involved.
*Sessions are conducted in English and require active participation of all attendees. Required readings are also in English. For more details or questions, write to: iap.symposia@uam.es
When: July 23-27, 2018
Where: 29 Oxford Street. Cambridge, MA 02138
Participation Fee: 1,500 USD*
* Fee includes: tuition, curricular materials, and some meals.
Scholarships: A limited number of partial scholarships and full scholarships are available. For partial scholarship recipients IAP will cover 40% of the participation fee (600 USD), and the cost for the recipient will be 900 USD. To apply for a scholarship, please explain in your cover letter in the application form a) your interest in attending the program and b) your reasons for requesting a scholarship.
For more information go to http://www.uam.es/otros/rccdr/clinical-research-program.html
Webinar RedETSA – “Revisiones rápidas y Evaluación de Tecnologías Sanitarias”
Tenemos el agrado de invitarlos a la 21ra edición del programa de Webinars de RedETSA, el próximo miércoles, 28 de marzo, a las 11hs, horario de Washington DC.
El Dr. Sebastián García Martí, coordinador del departamento de EE y ETS del Instituto de Efectividad Clínica y Sanitaria (IECS), de Argentina, dará una presentación sobre “Revisiones rápidas y Evaluación de Tecnologías Sanitarias”.
El link de WebEx que utilizaremos es el siguiente: https://goo.gl/vpiiWu
Por favor, siéntanse libres de difundir esta invitación a todos aquellos a quienes pueda serles de interés.
Enviamos más abajo una tabla con el horario correspondiente a cada país.
Contamos con su presencia.
Saludos cordiales,
Secretariado RedETSA
